Funding for this research was provided by:
U.S. Department of Defense (CA160997)
National Cancer Institute (R01-CA124704, R01-CA183804, R01-CA216855)
A.Q.H. was also supported by the Mayo Clinic Clinician Investigator Award and the William J. and Charles H. Mayo Professorship
Received: 25 February 2019
Accepted: 1 September 2020
First Online: 28 September 2020
: MAqCI is the subject of US utility patent applications 15/780,768 and 14/906,055. Intellectual property related to MAqCI is owned by the Johns Hopkins University and licenced to RecurX Bio, Inc., of which K.K. is a co-founder, consultant and board member. K.K. has a financial interest in RecurX Bio, Inc., which is subject to certain restrictions under university policy. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.